IMMUNE 3D™ is ideal for screening the biology, mechanism and function of IO drug candidates. The system uses HLA-matched cell platforms and Keytruda Resistant TIL and tumor cells or fresh patient-derived cells.

Immuno-oncology has gained prominence in the treatment of cancer. IMMUNE 3D™ is a unique platform that can be designed to discover novel drug candidates in immuno-oncology.

Please contact us to learn more.